United Therapeutics ( NASDAQ: UTHR) has entered into two accelerated share repurchase deal to buy back an aggregate of $1 billion of its common stock. The company will repurchase these shares as part ...

NEW YORK CITY, NEW YORK / ACCESS Newswire / August 1, 2025 / D. Boral ARC Acquisition I Corp. (the "Company") today announced the closing of its initial public offering of 25,000,000 units at a price ...

Key Points InterDigital delivered GAAP revenue of $300.6 million in Q2 2025, surpassing GAAP revenue estimates by 55.8%. A major Samsung arbitration win and a new HP license agreement was a core ...

Electronic Arts (EA) has captured significant attention with the unveiling of Battlefield 6, scheduled for release in October 2025, highlighting advancements like the Kinesthetic Combat System and ...

THOUSAND OAKS, Calif., Aug. 1, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN ) today announced that its Board of Directors declared a $2.38 per share dividend for the third quarter of 2025. The dividend ...

Mr. Mansoor Jan, MAX Power CEO, commented:“We welcome Eric Sprott as a major new investor in MAX Power and we appreciate his support for the largest permitted Natural Hydrogen project in Canada. We ...

Detailed price information for United Therapeutic (UTHR-Q) from The Globe and Mail including charting and trades.

Aurora Innovation reported its first GAAP revenue of $1 million in Q2 2025, exceeding the analyst estimate by 101.6% (GAAP, Q2 2025). GAAP loss per share was $ (0.11) in Q2 2025. GAAP loss per share ...

A Paradise Acquisition Corp. (Nasdaq: APADU) (the "Company"), a blank check company incorporated as a British Virgin Islands ...

Dubai Financial Market (DFM) today announced its consolidated financial results for the six-month period ending 30 June 2025, ...

They comprise 2.4% of the broader U.S. Market Index, yet are up 10.7% year-to-date. Compare that to technology stocks, which ...

Analysts have provided Freshpet with 7 ratings, resulting in a consensus rating of Outperform. The average one-year price target stands at $94.71, suggesting a potential 38.63% upside.